Phlorizin decreased renal GTTR uptake, and increased serum drug levels <i>in vivo</i>. by Meiyan Jiang (438439)

Results of comparison between Model5 and Model9. by Taiga Mori (21410076)

Results of comparison between Model5 and Model10. by Taiga Mori (21410076)

Negative ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). by Peng-fei Han (694841)

Positive ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). by Peng-fei Han (694841)

Immune pathways in <i>Ae</i>. <i>aegypti</i> mosquitoes infected by DENV. by Ju-Mei Wang (6589220)

“…<p><b>A</b>, Heatmap of transcriptional variation in expression of immune-related genes (ROS pathways and AMP genes) in DENV-infected mosquitoes. CC_1d_C, carcass 1 day post normal blood meal; CC_1d_I, carcass 1 day post DENV-infected blood meal; CC_2d_C, carcass 2 days post normal blood meal; CC_2d_I, carcass 2 days post DENV-infected blood meal; CC_7d_C, carcass 7 days post normal blood meal; CC_7d_I, carcass 2 days post DENV-infected blood meal; MG_1d_C, midgut 1 day post normal blood meal; MG_1d_I, midgut 1 day post DENV-infected blood meal. …”

Effects on fecundity of nanoparticle-treated <i>Ae</i>. <i>aegypti</i> larvae. by Mona Doshi (9421955)

“…<p>Third (3^rd) instar larvae that were treated with nanoparticles in <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0008654#pntd.0008654.g006" target="_blank">Fig 6</a> experiments were then allowed to emerge as adults and were given a blood meal five days post emergence; the resultant eggs were collected, weighed and characterized. …”

Serotype-specific penicillin non-susceptibility during different PCV periods in Iceland, Romania, Spain and Belgium [68, 69, 76, 78, 84, 85]. by Heloisa Ricci Conesa (18291210)

Subjects:

Procedures of sampling and measurements. by Xuegang Mao (599968)

Subjects:

Introduction status of PCVs in European countries over time. by Heloisa Ricci Conesa (18291210)

Subjects:

Data extraction grid. by Heloisa Ricci Conesa (18291210)

Subjects:

Incidence rates of AOM cases. by Heloisa Ricci Conesa (18291210)

Subjects:

Inclusion criteria. by Heloisa Ricci Conesa (18291210)

Subjects:

PRISMA flow diagram for the literature search. by Heloisa Ricci Conesa (18291210)

Subjects:

Estimates for direct medical and total costs per AOM episode (2020 EUR), by country [35, 96–100]. by Heloisa Ricci Conesa (18291210)

Subjects:

Vertical distributions in the three field settings. by Xuegang Mao (599968)

Subjects:

Fig 5 - by Kellie J. Walters (10451329)

Subjects:

<i>prx-5/6</i> mutations likely cause a decrease in mmBCFA degradation. by Rencheng Wang (463927)

“…<i>elo-5</i>(<i>lf</i>)<i>; Ex</i>[<i>elo-6</i>] is a transgenic strain that significantly overexpressed the <i>elo-6</i> gene and was not sufficient to suppress the L1 arrest phenotype of <i>elo-5</i>(<i>lf</i>). …”

HAstV-1 infection leads to a decrease in epithelial markers while increasing mesenchymal markers. by Virginia Hargest (12447014)

Heterocene Catalysts and Reaction Temperature Gradient in Dec-1-ene Oligomerization for the Production of Low Viscosity PAO Base Stocks by Ilya E. Nifant’ev (1561813)

Subjects: